From p.moreover.com
()
Psoriasis Treatment Advice
Advice on psoriasis treatments and relieving stress to help scratch the physical and emotional pain of psoriasis skin disease.
(HealthDayNews) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com: Psoriasis If you have moderate-to-severe plaque psoriasis, you may qualify for this study of an investigational medication.
More perspectives...
NEW YORK (Reuters Health) - As many as 14% of patients with psoriasis may also have psoriatic arthritis, according to a report in the October 15th Arthritis & Rheumatism.
From rehabpub.com
()
- EADV: Agent Clears Lesions, Lessens Psoriatic Arthritis (news.google.com)
John DelleCave knows how difficult it can be to live with psoriasis. That's because he does it every day. He's had the disease, which causes scaly patches on his skin and scalp, for years. DelleCave h...
More perspectives...
From webwire.com
()
DEAR DR. GOTT: I recently wrote you regarding my experience with psoriasis, for which my husband (a pathologist and professor) recommended that I take fish oil and vitamin D3. I had very good results and wanted to share them with your readers.
More perspectives...
From static.canadaeast.com
()
The U.S. Food and Drug Administration approved Stelara (ustekinumab), a biologic product for adults who have a moderate to severe form of psoriasis. Plaque psoriasis is an immune system disorder that results in the rapid overproduction of skin cells.
From medicalnewstoday.com
()
- Daily News: FDA Approves New Drug to Treat Psoriasis (news.google.com)
- Stopping the itch: a new drug to treat psoriasis (search.live.com)
- FDA Approves Biologic to Treat Psoriasis (biopharminternational.findpharma.com)
Incyte Corporation (Nasdaq:INCY) announced positive clinical trial results for a topical formulation of its lead janus kinase (JAK) inhibitor, INCB18424, in psoriasis. These results were obtained from a multi-center three-month Phase IIb trial comparing three once-daily doses of topical INCB18424 to vehicle in 200 patients with mild-to-moderate psoriasis.
More perspectives...
From medicalnewstoday.com
()
avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the results of its first DRTV test week.
More perspectives...
From news-medical.net
()
Scalp psoriasis and seborrheic dermatitis of the scalp can be difficult to differentiate.
Sponsored by:Chemotherapy.com - http://www.chemotherapy.com
From mayoclinic.com
()
- Psoriasis Scalp Treatment: Treating Scalp Psoriasis Naturally (associatedcontent.com)
Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis.
More perspectives...
From medicalnewstoday.com
()
People on immunosuppressants should receive vaccines and take extra precaution
PORTLAND, Ore., Oct. 13 /PRNewswire-USNewswire/ -- People with psoriasis and/or psoriatic arthritis who are taking biologic or non-biologic immunosuppressive medications should receive the inactived forms of both seasonal influenza and H1N1 (swine flu) vaccines as soon as possible, according to aread more
From freshnews.com
()
- EADV: Scalp, Nail Psoriasis Improve with TNF Inhibitor (news.google.com)

